It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
More Than Just a Hospital
What About Vaccinating Kids?
The Songs of Spring
What If the Vaccine Came to You?
Old Drugs, New Disease
Most Schools Closed in 1918. What Happened?
Pfizer's Moonshot
Play Ball!
Balancing Faith and Safety
What Went Wrong at the CDC
Inside the White House with Dr. Deborah Birx
The Debate Over Vaccine Mandates
Should I Stay or Go?
Jumping the Vaccine Line
How to Vaccinate the Entire World
An Update on Airborne Transmission
Reducing Loneliness by Lending a Hand
Me, Myself and BMI
The Perfect Storm
In Sickness and in Health
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
What’s That Rash?
The Coronavirus Podcast
Coronavirus Central